Abstract
Those antidepressant drugs that are, in wide clinical use decrease response rate and increase reinforcement rate when administered to rats performing on a differential-reinforcement-of-low-rate 72-s (DRL 72-s) schedule. Drugs that are not antidepressants do not have this effect. In this experiment, the following were examined for their effects on a DRL 72-s schedule: tranzodone, zimelidine, fluoxetine, and bupropion (atypical antidepressants); electroconvulsive shock (ECS, which is an effective treatment for depression); and haloperidol and clozapine (antipsychotic drugs). Trazodone (3.12–25.00 mg/kg), fluoxetine (10–20 mg/kg), and ECS decreased response rate and increased reinforcement rate. Zimelidine (20 mg/kg) increased reinforcement rate and nonsignificantly decreased response rate. At doses between 2.5 and 40 mg/kg, bupropion had no effect on reinforcement rate or response rate, but at 60 mg/kg response rate was increased and reinforcement rate was nonsignificantly decreased. At the higher dose, the effects of bupropion resemble those of a psychomotor stimulant. Haloperidol (0.04 mg/kg) and clozapine (2.5–10.0 mg/kg) decreased response rate and reinforcement rate. These results, suggest that the DRL 72-s schedule may be useful for testing the antidepressant potential of new drugs.
Similar content being viewed by others
References
Abrams R (1975) What's new in convulsive therapy? In: Arieti S, Chrozanowski G (eds) New dimension in psychiatry. Wiley, New York, pp 86–97
Agnoli A, Piccione M, Casacchia M, Fazio C (1974) Trazodone versus desipramine: A double-blind study on the rapidity of the antidepressant effect. In: Ban TA, Silverstrini B (eds) Modern problems of pharmaco-psychiatry, vol 9. Karger, Basel, pp 190–198
Ando K (1975) Profile of drug effects on temporally spaced responding in rats. Pharmacol Biochem Behav 3:833–841
Cassano GB, Conti L, Dell'Osso L, Massimetti G (1982) Four new antidepressants (trazodone, mianserin, nomifensine, caroxazone): Results of controlled trials. In: Costa E, Racagni G (eds) Typical and Atypical antidepressants: Clinical practice. Raven, New York, pp 125–140
Chouinard G (1983) Bupropion and amitriptyline in the treatment of depressed patients. J Clin Psychiatry 44:121–129
Feighner JP (1980) Trazodone, a triazopyridine derivative in primary depressive disorder. J Clin Psychiatry 41:250–255
Ford RD, Balster RL (1976) Schedule-controlled behavior in the morphine-dependent rat. Pharmacol Biochem Behav 4:569–573
Griffith JD, Carranza J Griffith C, Miller LL (1983) Bupropion: Clinical assay for amphetamine-like abuse potential. J Clin Psychiatry. 44:206–208
Harto-Truax N, Stern WC, Miller LL, Sato TL, Cato AE (1983) Effects of bupropion on body weight. J Clin Psychiatry 44:183–186
Hollister LE (1978) Psychiatric disorders. In: Melmon KL, Morelli HF (eds) Clinical pharmacology: Basic principles in therapeutics. MacMillan, New York, pp 842–873
Howard JL, Jones CN, McBennett ST (1978) Discriminative stimulus properties of antidepressants. In: Colpaert FC, Rosencrans JA (eds) Stimulus properties of drugs: Ten years of progress. Elsevier/North-Holland, Amsterdam, pp 157–166
Howard JL, Soroko, FE, Cooper BR (1981) Empirical behavioral models of depression with emphasis on tetrabenazine antagonism. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven, New York, pp 107–120
Klerman GL, Cole JO (1965) Clinical pharmacology, of imipramine and related antidepressant compounds. Pharmacol Rev 17:101–141
Laties VG, Weiss B (1962) Effects of alcohol on timing behavior. J Comp Physiol Psychol 55:85–91
Longo VG, Scotti de Carolis A (1974) Pharmacological features of trazodone. In: Ban TA, Silvestrini B (eds) Modern problems of pharmacopsychiatry, vol. 9. Karger, Basel, pp 95–109
Malick JB (1981) Yohimbine potentiation as predictor of antidepressant action. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioral and cinical perspectives. Raven, New York, pp 141–155
McGuire PS (1980a) The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rate schedule in rats. J Pharmacol Exp Ther 214:635–641
McGuire PS, Seiden LS (1980b) Differential effects of imipramine in rats as a function, of DRL schedule value. Pharmacol Biochem Behav 13:691–694
Mendels J, Amin MM, Chouinard G, Cooper AJ, Miles JE, Remick RA, Saxena B, Secunda SK, Singh AN (1983) A comparative study of bupropion and amitriptyline in depressed outpatients. J Clin Psychiatry 44:118–120
Montgomery SA, Montgomery DB, McAuley R, Rani SJ, Roy D (1982) Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: Clinical practice. Raven, New York, pp 35–42
Nomura S, Shimizu J, Kinjo M, Kametau H, Nakazawa T (1982) A new behavioral test for antidepressant drugs. Eur. J Pharmacol 83:171–175
O'Donnell JM, Seiden LS (1982) Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate. Psychopharmacology 78:214–218
O'Donnell JM, Seiden LS (1983) Differential-reinforcement-of-low-rate 72-sec schedule: Selective effects of antidepressant drugs. J Pharmacol Exp Ther 224:80–88
Pearl RG, Seiden LS (1976) The existence of tolerance to and cross-tolerance between d-amphetamine and methylphenidate for their effects on milk consumption and on differential-reinforcement-of-low-rate performance in the rat. J Pharmacol Exp Ther 198:635–647
Pollard GT, Howard JL (1983) Effects of imipramine, bupropion, chlorpromazine, clozapine, diphenhydramine and prefeeding on rats responding under a differential-reinforcement-of-low-rate 72-s schedule (DRL 72). Soc Neurosci. Abstr, 36.2
Porsolt RD (1981) Behavioral despair. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioral and clinical perspectives. Raven, New York, pp 121–139
Porsolt RD, Anton G, Blavet N, Jalffe M (1977) Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391
Quitkin F, Rifkin A, Klein DF (1979) Monoamine oxidase inhibitors: A review of antidepressant effectiveness. Arch. Gen Psychiatry 36:749–760
Sanger DJ, Key M, Blackman DE (1974) Differential effects of chlordiazepoxide and d-amphetamine on responding maintained by a DRL schedule of reinforcement. Psychopharmacology 38:159–171
Shopsin B, Cassano GB, Conti L (1981) An overview of new “second generation” antidepressant compounds: Research and treatment implications. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioral and clinical perspectives. Raven, New York, pp 219–251
Silvestrini B, Lisciani R (1973) Pharmacology of trazodone. Curr Ther Res 15:749–754
Snapper AG, Kadden RM (1973) Time-sharing on a small computer based on a behavioral notation system. In: Weiss B (ed) Digital computers in the behavioral laboratory. Appleton-Century-Crofts, New York, pp 41–97
Stern WC, Harto-Truax N, Rogers J, Miller L (1982) Clinical profile of the novel antidepressant bupropion. In: Costa E, Racagni G (eds) Typical and atypical, antidepressants: Clinical practice. Raven, New York, pp 21–34
Sulser F (1982) Antidepressant drug research: Its impact on neurobiology and psychobiology. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: molecular mechanisms. Raven, New York, pp 1–20
Turski L, Czuazwor SJ, Turski W, Kleinok Z (1981) Effects of trazodone, mianserin, iprinodole and zimelidine on wet dog shakes produced by carbachol in rats. J Pharm Pharmacol 33:670–671
Van Wyck Fleet J, Manberg PJ, Miller LL, Harto-Truax N, Sato T, Fleck RJ, Stern WC, Cato AE (1983) Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry 44:191–196
Vogel JR (1975) Antidepressants and mouse-killing (muricide) behavior. In: Fielding S, Lal H (eds) Antidepressants. Futura, New York, pp 99–112
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seiden, L.S., Dahms, J.L. & Shaughnessy, R.A. Behavioral screen for antidepressants: The effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Psychopharmacology 86, 55–60 (1985). https://doi.org/10.1007/BF00431684
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431684